Conquer Cancer, the ASCO Foundation, announced its 2020 grant and award recipients in conjunction with the 2020 ASCO Virtual Scientific Program. The awards will support researchers with projects spanning many areas in cancer care, including immunotherapy, lung and breast cancers, and palliative care.
“Conquer Cancer is proud to recognize this group of talented clinical cancer researchers,” said Thomas G. Roberts, Jr, MD, FASCO, Chair of the Conquer Cancer Board of Directors. “From supporting research projects that rarely see funding to providing that first, vital research grant to a young scientist, Conquer Cancer is cultivating the next generation of breakthroughs for every cancer, every patient, everywhere.”
Research Professorship in Breast Cancer Disparities
The Research Professorship provides funding to full professors who have made significant contributions to cancer research and are dedicated to mentoring the next generation of researchers. This year’s Research Professorship in Breast Cancer Disparities recipient is Jeffrey N. Weitzel, MD, of City of Hope. Dr. Weitzel will receive $500,000 over the next 5 years to support his research project, “Multimodal approach to address disparities in access to genomic cancer risk assessment, screening, and precision prevention among underserved women in the Americas.”
Advanced Clinical Research Award in Breast Cancer
The Advanced Clinical Research Award in Breast Cancer supports physician-scientists committed to conducting original breast cancer research in an area that is currently not funded. The 2020 Conquer Cancer–Breast Cancer Research Foundation® Advanced Clinical Research Award recipient is David W. Cescon, MD, PhD, of Princess Margaret Cancer Centre. Dr. Cescon will receive $450,000 over the next 3 years to further his research project, “A liquid biopsy-guided umbrella trial for CDK4/6 inhibitor–resistant ER-positive breast cancer.”
Career Development Awards
The Career Development Award (CDA) is a 3-year grant that funds clinical investigators who have received their initial faculty appointment and are working to establish an independent, patient-focused, clinical cancer research program. This year, Conquer Cancer will award 15 CDAs to promising clinicians.
Young Investigator Awards
The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in oncology. The grant supports preclinical and clinical cancer research projects by oncologists who are undergoing a career transition from a fellowship program to a faculty appointment. Eighty-one investigators will receive YIAs this year.
Global Oncology Young Investigator Awards
The Global Oncology Young Investigator Award (GO YIA) supports early-career researchers with projects focused on addressing global health needs in cancer care and research. This year three researchers will be awarded GO YIAs.
Gateway for Cancer Research Discovery Grant in Immunotherapy Research
The Gateway Discovery Grant Program supports innovative early-phase clinical trials with great potential to advance breakthrough cancer research. The inaugural recipient is David C. Linehan, MD, of the University of Rochester Medical Center/Wilmot Cancer Institute. Dr. Linehan will receive up to $1.5 million over 3 years from Gateway for Cancer Research for his study, “A phase IB/II trial of immunotherapy with nivolumab and pepinemab combined with first-line FOLFIRINOX for treating patients with unresectable pancreatic adenocarcinoma.”
The 2020 Gateway Discovery Grant in Immunotherapy Research is supported by Gateway for Cancer Research with Conquer Cancer as the scientific partner. A full list of 2020 grant and award recipients is available on CONQUER.ORG.